Kitov Pharma is a clinical-stage company that advances first-in-class therapies to overcome tumor-immune evasion and drug resistance in order to create successful, long-lasting treatments for patients with hard-to-treat cancers.

Kitov’s oncology pipeline comprises two drugs. CM-24 is a monoclonal antibody blocking CEACAM1, a novel immune checkpoint that supports tumor-immune evasion and survival through multiple pathways. NT-219 is a potential first-in-class small molecule bi-specific inhibitor of two key cancer resistance pathways – STAT3 and IRS1/2.

Website : [ Ссылка ]

PlatSharpTradez Discord : [ Ссылка ]

Questrade referral code: 426033354436861

свернуть